Malavika Aatur Mehta and Niraalie Meynon (non-promoters) sold 11,43,245 equity shares of Expo Gas Containers Ltd, representing 5.01% of its share capital. Following this open market disposal on April 9, 2026, their aggregate holding decreased from 8.25% to 3.24%.
Shiva Texyarn Ltd announced that the Hon'ble High Court of Mumbai has set aside an arbitration award involving M/s. Louis Dreyfus Company India Pvt. Ltd. The ₹1.44 Crore dispute was resolved through a mutual compromise agreement and consent terms. Consequently, the petition stands disposed of, concluding the litigation.
Power Finance Corporation Debt & Borrowing: ₹284,572 Cr
Power Finance Corporation Limited disclosed its outstanding private placement debt securities as of March 31, 2026. The total outstanding value of these securities amounted to ₹284,571.73 Crore. This filing follows SEBI's operational circular requirements for debt securities.
Systematix Corporate Services Limited is investing ₹35.0 Crore in its wholly owned subsidiary, Systematix Shares and Stocks (India) Limited. The investment involves subscribing to 17,50,036 equity shares at ₹200 each to fund working capital. This strategic move aligns with a previously approved shareholder resolution to strengthen the subsidiary's capital market operations.
Sai Capital Ltd confirmed it does not qualify as a Large Corporate under SEBI's framework as of March 31, 2026. The company reported outstanding borrowings of ₹4.99 Crore, which is below the regulatory threshold. This disclosure ensures compliance with SEBI debt-raising norms for listed entities.
Saven Technologies Ltd informed BSE that it is not a 'Large Corporate' as per SEBI's debt-raising framework. The company reported zero outstanding borrowings as of March 31, 2026. This routine regulatory filing confirms the company is not currently subject to mandatory debt-market borrowing requirements for large entities.
Zota Health Care Limited clarified its proposal to increase borrowing and investment limits from ₹500 Crore to ₹1,000 Crore following a proxy advisory report. The company intends to maintain headroom for strategic acquisitions and working capital support for its subsidiary, Davaindia Health Mart Limited, to manage its extensive store network.
Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam Investment and Finance Company Limited submitted its quarterly utilization statement for March 2026. The CFO certified that Commercial Paper proceeds were used for disclosed purposes and adhered to SEBI listing conditions.
N K Industries Limited (BSE: 519494) submitted its initial disclosure for FY 2025-26, confirming it does not meet the SEBI criteria for a 'Large Corporate'. The company reported zero outstanding borrowings as of March 31, 2026.
National Oxygen Limited announced the sad demise of Mr. Gajanand Saraf, Whole-Time Director of the company, on April 6, 2026. The company acknowledged his vast experience and leadership. This regulatory filing complies with SEBI Listing Regulations following the cessation of his tenure due to death.
Alkem Laboratories Limited incorporated a wholly owned subsidiary, Alkem Pharma Trading FZCO, in Dubai, UAE, on March 27, 2026. The ₹9.18 Crore investment aims to facilitate pharmaceutical exports to African, South East Asian, and non-UAE markets. This strategic move strengthens Alkem's international presence and export capabilities.
Shivalic Power Control Limited informed the National Stock Exchange that it is exempt from submitting the quarterly Corporate Governance Report. As an SME-listed entity, it cited Regulation 15(2) of SEBI LODR Regulations for this non-applicability for the quarter ended March 31, 2026.
Mr. Vatsankit Shah (Promoter Group) acquired 8,45,906 shares (2.00%) of Global Surfaces Limited from M/s Vatsankit Shah Trust through an off-market inter-se transfer. This transfer followed the dissolution of the trust, leaving the aggregate promoter group shareholding unchanged at 73.25%.
Skyline Millars Limited has scheduled a Board of Directors meeting on April 22, 2026. The board will primarily consider and approve the audited financial results for the fourth quarter and full year ending March 31, 2026.
Avonmore Capital & Management Services Acquisition
Avonmore Capital & Management Services Ltd. successfully completed the acquisition of a 100% stake in Excelling Geo & Engineering Consultant Private Limited on April 13, 2026. The target entity is now a wholly owned subsidiary. This follows previous intimations regarding the fulfillment of conditions precedent stipulated in the Share Purchase Agreement.
Transpek Industry Limited confirmed it does not fall under the 'Large Corporate' category as of March 31, 2026. Consequently, the company is not required to file annual disclosures for incremental borrowings under the SEBI debt-raising framework for FY 2025-2026.
GACM Technologies Limited confirmed it does not qualify as a Large Corporate as of March 31, 2026, under SEBI debt-raising norms. Consequently, the requirement for mandatory borrowing through debt securities is not applicable. The company reported zero incremental borrowing and no shortfalls for the 2025-26 fiscal year.
Godrej Industries Limited has redeemed Commercial Papers (CP) worth ₹75 Crore with a maturity date of April 13, 2026. The company confirmed compliance with payment obligations under SEBI Master Circular guidelines. This redemption reduces the company's outstanding short-term debt liabilities.
GIC Private Limited, a non-promoter institutional investor, sold 2,66,269 equity shares of Shriram Finance Limited via open market sale on 9 April 2026. This transaction reduced GIC's aggregate holding from 4.287% to 4.276%. The disposal reflects a minor stake reduction by a significant institutional shareholder.
Systematix Corporate Services Fund Raise of ₹35 Cr
Systematix Corporate Services Ltd invested ₹35.00 Crore in its wholly-owned subsidiary, Systematix Shares and Stocks (India) Limited. The investment was made via a rights issue of 17,50,036 equity shares at ₹200 each. The funds will support the subsidiary's working capital requirements in the capital markets sector.
Transpek Industry Limited disclosed that it does not qualify as a Large Corporate under SEBI's framework as of March 31, 2026. The company reported nil outstanding borrowings and carries an ICRA A+ (Stable) credit rating. This annual regulatory filing confirms the company is not subject to mandatory incremental borrowing requirements through debt securities.
Best Agrolife Limited submitted its annual disclosure confirming it is not identified as a 'Large Corporate' for FY 2025-26. The company remains outside the mandatory SEBI framework for incremental debt sourcing via debt securities. This filing is a routine regulatory compliance requirement for listed entities.
CESC Limited submitted a certificate confirming the full utilization of proceeds raised via Commercial Papers for the quarter ended March 31, 2026. The funds were used for purposes disclosed in offer documents, in adherence with SEBI listing conditions.
Enterprise International Ltd confirmed it does not meet the SEBI criteria for a 'Large Corporate' as of March 31, 2026. The company reported zero outstanding borrowings and no credit rating. This regulatory filing complies with SEBI's debt security issuance framework for large entities.
Anondita Medicare Limited submitted a certificate stating that quarterly Corporate Governance report filing is not applicable to the company. Being listed on the NSE Emerge platform (SME Exchange), it is exempt from Regulation 27 of SEBI (LODR) Regulations, 2015. This is a routine regulatory compliance filing.
GACM Technologies Limited submitted its initial disclosure for FY 2026-27, confirming it does not fall under the 'Large Corporate' category. The company reported zero outstanding borrowings as of March 31st. This regulatory filing complies with SEBI norms regarding fund raising via debt securities by large entities.
Petro Carbon and Chemicals Limited submitted its quarterly statement of investor complaints for the period ended March 31, 2026. The company reported zero pending, received, or unresolved complaints during the quarter. This routine compliance filing confirms efficient investor grievance redressal mechanisms.
Ishita Drugs & Industries Ltd submitted a NIL statement of deviation or variation under SEBI Regulation 32(1). The company confirmed it raised no funds through public, rights, or preferential issues during FY 2025-26. This routine regulatory filing maintains compliance and transparency regarding the company's capital raising activities.
Mankind Pharma Limited's Board has approved the winding-up of its Sri Lankan wholly owned subsidiary, Mankind Pharma Lanka (Private) Limited. The entity had no active operations and became unviable due to regulatory changes. This closure is not expected to materially impact the company's consolidated financials.
Chartered Logistics Ltd (BSE: 531977) disclosed that it does not meet the 'Large Corporate' criteria per SEBI's debt-raising framework. The company reported outstanding borrowings of ₹23.26 Crore as of March 31, 2026. This routine regulatory filing confirms the company is currently exempt from mandatory incremental borrowing through debt securities.